Market exclusivity is a period during which a drug manufacturer has the exclusive right to sell a new drug, preventing generic competition and allowing recovery of research and development costs. This is granted by regulatory agencies to incentivize innovation and can run concurrently with patent protection, but is distinct from patent rights.